Changeflow GovPing Healthcare & Life Sciences Etoricoxib, Diacerein, Osteoarthritis Pain, 3 M...
Routine Notice Added Final

Etoricoxib, Diacerein, Osteoarthritis Pain, 3 Mexican Cities

Email

Summary

NCT07549386 is a Phase 3 clinical trial registered on ClinicalTrials.gov evaluating etoricoxib and diacerein for the treatment of osteoarthritis pain. The study is being conducted across three cities in Mexico. No additional study details, enrollment figures, or start dates are provided in the source record.

Published by NIH on clinicaltrials.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors ClinicalTrials.gov - Phase 3 Trials by Start Date for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 12 changes logged to date.

What changed

NCT07549386 is a newly registered Phase 3 clinical trial on ClinicalTrials.gov investigating etoricoxib and diacerein for osteoarthritis pain. The trial is being conducted across three Mexican cities. The source record contains only the study title and trial identifier; no inclusion criteria, enrollment size, endpoints, or sponsor information is provided.

Affected parties — sponsors, contract research organizations, and clinical investigators conducting trials in Mexico — should monitor ClinicalTrials.gov for completion of the trial record with full protocol details, enrollment milestones, and results posting upon trial completion.

Archived snapshot

Apr 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Show glossary

Get daily alerts for ClinicalTrials.gov - Phase 3 Trials by Start Date

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Pharmaceutical companies Clinical investigators
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug trial registration Clinical study
Geographic scope
MX MX

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Clinical Operations
Topics
Healthcare Public Health

Get alerts for this source

We'll email you when ClinicalTrials.gov - Phase 3 Trials by Start Date publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!